Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RELIEF: Real World Evidence on ELInzanEtant For the Treatment of Vasomotor Symptoms in Postmenopausal Women

NCT07490431 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT07490431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07490431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RELIEF: Real World Evidence on ELInzanEtant For the Treatment of Vasomotor Symptoms in Postmenopausal Women
Lead sponsor
Bayer
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2029
Enrollment
2,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms (vms) associated with menopause